Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 19 of the 20 references it cites were found in a registry or an index.

A double-blind, placebo-controlled study of antidepressant augementation with mirtazapine

Carpenter, Linda L, Yasmin, Sarah, Price, Lawrence H · 2002 · Biological Psychiatry

Abstract

Background A previous pilot study of open-label mirtazapine augmentation conducted by the authors in 20 depressed patients yielded a 55% response rate at week 4. A double-blind controlled trial was undertaken to further elucidate the efficacy of this intervention. Methods 26 adult outpatients with persistent major depression despite adequate antidepressant monotherapy were randomized to receive 4 weeks of mirtazapine or placebo augmentation. Mirtazapine was begun at 15 mg at bedtime, with possible titration to 30 mg at bedtime per physician's discretion after week 1. Results Categorical positive response rate at end point was 64% for active drug and 20% for placebo. Remission rates were 45.4% and 13.3% for active drug and placebo groups, respectively, Mirtazapine demonstrated statistically significant superiority to placebo on most major outcome measures, and was associated with improvement in overall functioning and quality of life. There were no significant group differences with regard to emergent side effects, weight change, or serum concentrations of primary antidepressants. Conclusions Mirtazapine appears safe and effective for short-term antidepressant augmentation.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0006-3223(01)01262-8

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 20 references

Cited by

See all 245

Metadata

Authors
Carpenter, L. L., Yasmin, S., & Price, L. H.
Affiliations
Brown University (US)
Corresponding author
Carpenter, Linda L
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2002-01
Volume
51
Issue
2
Pages
183-188
ISSN
0006-3223 (ISSN-L)
OpenAlex
W1979281142
Cited by
244
References
20
Citations by year
2026: 3 · 2025: 3 · 2024: 4 · 2023: 4 · 2022: 9 · 2021: 6 · 2020: 7 · 2019: 9 · 2018: 3 · 2017: 6 · 2016: 12 · 2015: 17 · 2014: 10 · 2013: 10 · 2012: 15
FWCI
8.13
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Biological Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Keywords
mirtazapine, antidepressant augmentation, major depressive disorder, treatment-resistant depression, antidepressant monotherapy, remission, quality of life, drug safety, adverse effects
MeSH terms
Mirtazapine, Adult, Antidepressive Agents, Antidepressive Agents, Tricyclic, Depressive Disorder, Major, Major Depressive Disorder, Double-Blind Method, Drug Synergism, Drug Therapy, Combination, Female, Humans, Male, Mianserin, Middle Aged

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A double-blind, placebo-controlled study of antidepressant augementation with mirtazapine. https://app.cochat.ai/papers/10.1016/s0006-3223(01)01262-8
The paper
Carpenter, L. L., Yasmin, S., & Price, L. H. (2002). A double-blind, placebo-controlled study of antidepressant augementation with mirtazapine. Biological Psychiatry. https://doi.org/10.1016/s0006-3223(01)01262-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.